JanMKitzen

Jan M Kitzen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

5 citations
e-Cigarettes for smoking cessation: Do they deliver?
Jan M. Kitzen, Jamie L. McConaha, Megan L. Bookser, Joseph V. Pergolizzi, Robert W. Taylor
Journal of Clinical Pharmacy and Therapeutics. 2019-04-04
34 citations
Sunscreen bans: Coral reefs and skin cancer
Robert B. Raffa, Joseph V. Pergolizzi, Robert W. Taylor, Jan M. Kitzen
Journal of Clinical Pharmacy and Therapeutics. 2019-02-01

Journal Articles

Crisaborole and Apremilast: PDE4 Inhibitors with Similar Mechanism of Action, Different Indications for Management of Inflammatory Skin Conditions
Jan M. Kitzen, Joseph V. Pergolizzi Jr., Robert Taylor Jr., Robert B. Raffa, Pharmacy & Pharmacology, 9/2018
The Role of Medical Literature, Clinical Trials and Experimental Research in Drug Product-Injury Litigation: A Primer with Two Examples
Jan M. Kitzen, Joseph V. Pergolizzi Jr., Robert Taylor Jr., Robert B. Raffa, Pharmacy & Pharmacology, 6/2018

Other

The Role of Medical Literature, Clinical Trials and Experimental Research in Drug Product-Injury Litigation: A Primer with Two Examples
Kitzen JM
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85766
Crisaborole and Apremilast: PDE4 Inhibitors with Similar Mechanism of Action, Different Indications for Management of Inflammatory Skin Conditions
Kitzen JM
http://www.scirp.org/Journal/PaperInformation.aspx?PaperID=87194